Yabao Pharmaceutical Group Co., Ltd (600351.SS)
CNY 6.09
(0.0%)
CNY 6.09
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 226.33 Million CNY | 2.69% |
| 2022 | 220.39 Million CNY | 8.45% |
| 2021 | 203.21 Million CNY | 59.58% |
| 2020 | 127.34 Million CNY | -66.36% |
| 2019 | 378.52 Million CNY | 14.4% |
| 2018 | 330.86 Million CNY | 44.84% |
| 2017 | 228.42 Million CNY | 478.09% |
| 2016 | -60.41 Million CNY | -126.95% |
| 2015 | 224.15 Million CNY | 22.08% |
| 2014 | 183.61 Million CNY | 102.59% |
| 2013 | 90.63 Million CNY | -0.55% |
| 2012 | 91.13 Million CNY | -60.22% |
| 2011 | 229.08 Million CNY | 43.51% |
| 2010 | 159.63 Million CNY | 4.34% |
| 2009 | 152.99 Million CNY | 44.26% |
| 2008 | 106.05 Million CNY | 58.66% |
| 2007 | 66.84 Million CNY | 166.35% |
| 2006 | 25.09 Million CNY | -16.63% |
| 2005 | 30.1 Million CNY | -32.78% |
| 2004 | 44.78 Million CNY | 15.6% |
| 2003 | 38.74 Million CNY | 23.61% |
| 2002 | 31.34 Million CNY | 12.14% |
| 2001 | 27.94 Million CNY | 19.93% |
| 2000 | 23.3 Million CNY | 135.65% |
| 1999 | 9.88 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 76.23 Million CNY | 17.55% |
| 2024 Q1 | 125.34 Million CNY | 761.13% |
| 2024 Q2 | 64.84 Million CNY | -48.26% |
| 2023 Q2 | 61.24 Million CNY | -53.07% |
| 2023 Q3 | 53.55 Million CNY | -12.57% |
| 2023 Q4 | -18.95 Million CNY | -135.4% |
| 2023 FY | 226.33 Million CNY | 2.69% |
| 2023 Q1 | 130.49 Million CNY | 2792.8% |
| 2022 Q3 | 1.42 Million CNY | -95.58% |
| 2022 FY | 220.39 Million CNY | 8.45% |
| 2022 Q1 | 87.84 Million CNY | 175.5% |
| 2022 Q2 | 32.26 Million CNY | -63.27% |
| 2022 Q4 | -4.84 Million CNY | -440.15% |
| 2021 Q3 | 58.91 Million CNY | 29.19% |
| 2021 Q2 | 45.6 Million CNY | -31.75% |
| 2021 Q1 | 66.81 Million CNY | 214.22% |
| 2021 Q4 | 31.88 Million CNY | -45.87% |
| 2021 FY | 203.21 Million CNY | 59.58% |
| 2020 Q1 | 46.02 Million CNY | 122.52% |
| 2020 Q2 | 25.38 Million CNY | -44.84% |
| 2020 Q3 | 34.66 Million CNY | 36.55% |
| 2020 FY | 127.34 Million CNY | -66.36% |
| 2020 Q4 | 21.26 Million CNY | -38.66% |
| 2019 Q2 | 99.78 Million CNY | 15.18% |
| 2019 Q1 | 86.63 Million CNY | 2.97% |
| 2019 Q4 | -204.4 Million CNY | -387.59% |
| 2019 FY | 378.52 Million CNY | 14.4% |
| 2019 Q3 | 71.07 Million CNY | -28.77% |
| 2018 Q3 | 82.1 Million CNY | -17.7% |
| 2018 Q4 | 84.13 Million CNY | 2.48% |
| 2018 FY | 330.86 Million CNY | 44.84% |
| 2018 Q1 | 64.87 Million CNY | -3.75% |
| 2018 Q2 | 99.75 Million CNY | 53.78% |
| 2017 FY | 228.42 Million CNY | 478.09% |
| 2017 Q4 | 67.39 Million CNY | 50.29% |
| 2017 Q3 | 44.84 Million CNY | -43.57% |
| 2017 Q1 | 36.71 Million CNY | 157.58% |
| 2017 Q2 | 79.47 Million CNY | 116.46% |
| 2016 FY | -60.41 Million CNY | -126.95% |
| 2016 Q1 | 76.26 Million CNY | 1945.29% |
| 2016 Q4 | -63.76 Million CNY | -59.9% |
| 2016 Q2 | -33.04 Million CNY | -143.33% |
| 2016 Q3 | -39.87 Million CNY | -20.68% |
| 2015 Q3 | 74.42 Million CNY | 1.2% |
| 2015 Q1 | 80.31 Million CNY | 2126.73% |
| 2015 FY | 224.15 Million CNY | 22.08% |
| 2015 Q4 | -4.13 Million CNY | -105.55% |
| 2015 Q2 | 73.54 Million CNY | -8.43% |
| 2014 Q1 | 55.27 Million CNY | 975.22% |
| 2014 FY | 183.61 Million CNY | 102.59% |
| 2014 Q4 | 3.6 Million CNY | -94.44% |
| 2014 Q3 | 64.87 Million CNY | 8.39% |
| 2014 Q2 | 59.85 Million CNY | 8.28% |
| 2013 Q3 | 26.21 Million CNY | 20.71% |
| 2013 Q4 | 5.14 Million CNY | -80.39% |
| 2013 FY | 90.63 Million CNY | -0.55% |
| 2013 Q1 | 37.55 Million CNY | 34.08% |
| 2013 Q2 | 21.72 Million CNY | -42.16% |
| 2012 FY | 91.13 Million CNY | -60.22% |
| 2012 Q4 | 28 Million CNY | 216.76% |
| 2012 Q3 | 8.84 Million CNY | -70.83% |
| 2012 Q1 | 23.97 Million CNY | -83.18% |
| 2012 Q2 | 30.31 Million CNY | 26.44% |
| 2011 Q2 | -2.7 Million CNY | -106.52% |
| 2011 FY | 229.08 Million CNY | 43.51% |
| 2011 Q4 | 142.56 Million CNY | 198.97% |
| 2011 Q1 | 41.54 Million CNY | 56.79% |
| 2011 Q3 | 47.68 Million CNY | 1861.15% |
| 2010 Q2 | 47.4 Million CNY | -13.49% |
| 2010 FY | 159.63 Million CNY | 4.34% |
| 2010 Q4 | 26.49 Million CNY | -14.33% |
| 2010 Q3 | 30.92 Million CNY | -34.77% |
| 2010 Q1 | 54.8 Million CNY | 99.41% |
| 2009 Q3 | 44.6 Million CNY | -2.99% |
| 2009 FY | 152.99 Million CNY | 44.26% |
| 2009 Q4 | 27.48 Million CNY | -38.39% |
| 2009 Q2 | 45.98 Million CNY | 31.68% |
| 2009 Q1 | 34.92 Million CNY | 36.34% |
| 2008 Q2 | 25.98 Million CNY | -6.75% |
| 2008 FY | 106.05 Million CNY | 58.66% |
| 2008 Q4 | 25.61 Million CNY | -3.67% |
| 2008 Q3 | 26.58 Million CNY | 2.31% |
| 2008 Q1 | 27.86 Million CNY | 87.4% |
| 2007 Q1 | 13.71 Million CNY | 98.58% |
| 2007 Q2 | 15.62 Million CNY | 13.94% |
| 2007 Q3 | 22.62 Million CNY | 44.79% |
| 2007 Q4 | 14.87 Million CNY | -34.28% |
| 2007 FY | 66.84 Million CNY | 166.35% |
| 2006 Q2 | 2.93 Million CNY | -50.79% |
| 2006 Q4 | 6.9 Million CNY | -25.75% |
| 2006 FY | 25.09 Million CNY | -16.63% |
| 2006 Q1 | 5.95 Million CNY | 6.86% |
| 2006 Q3 | 9.3 Million CNY | 217.45% |
| 2005 Q2 | 3.53 Million CNY | -72.15% |
| 2005 Q1 | 12.69 Million CNY | 6.46% |
| 2005 Q3 | 8.3 Million CNY | 135.0% |
| 2005 Q4 | 5.57 Million CNY | -32.89% |
| 2005 FY | 30.1 Million CNY | -32.78% |
| 2004 Q4 | 11.92 Million CNY | -10.75% |
| 2004 Q2 | 7.03 Million CNY | -43.55% |
| 2004 FY | 44.78 Million CNY | 15.6% |
| 2004 Q1 | 12.46 Million CNY | 58.98% |
| 2004 Q3 | 13.35 Million CNY | 89.79% |
| 2003 Q2 | 9.7 Million CNY | 7.12% |
| 2003 Q1 | 9.05 Million CNY | 35.06% |
| 2003 FY | 38.74 Million CNY | 23.61% |
| 2003 Q4 | 7.84 Million CNY | -35.4% |
| 2003 Q3 | 12.13 Million CNY | 25.12% |
| 2002 Q4 | 6.7 Million CNY | -7.63% |
| 2002 Q3 | 7.25 Million CNY | -17.68% |
| 2002 Q2 | 8.81 Million CNY | 3.06% |
| 2002 FY | 31.34 Million CNY | 12.14% |
| 2002 Q1 | 8.55 Million CNY | 0.0% |
| 2001 FY | 27.94 Million CNY | 19.93% |
| 2000 FY | 23.3 Million CNY | 135.65% |
| 1999 FY | 9.88 Million CNY | 0.0% |